Elisabetta De Marinis

Pubblicazioni

Titolo Pubblicato in Anno
Nuclear miR-223 affects chromatin organization and regulates Flotillin-1 gene expression in myeloid progenitors MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES 2024
Nuclear miRNAs: Gene Regulation Activities INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2024
Plasmonic biosensors for real-time monitoring of harmful pathogens and biomolecules 2024 IEEE Research and Applications of Photonics in Defense Conference, RAPID 2024 2024
Remote adipose tissue-derived stromal cells of patients with lung adenocarcinoma generate a similar malignant microenvironment of the lung stromal counterpart JOURNAL OF ONCOLOGY 2023
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients LEUKEMIA 2023
Biomarkers in acute myeloid leukemia: From state of the art in risk classification to future challenges of RNA editing as disease predictor and therapy target ASPECTS OF MOLECULAR MEDICINE 2023
The epigenetic/transcriptional activity of nuclear mir-223 regulates flotillin-1 expression and function in myeloid differentiation 1st Epigenetics Society International Meeting “Epigenetics of Disease and Development” 2023
Serum albumin and nucleic acids biodistribution. From molecular aspects to biotechnological applications IUBMB LIFE 2022
The gene promoter binding activity of miR-223 induces flotillin-1 expression and function to regulate myeloid differentiation HAEMATOLOGICA 2022
Human platelet lysate‐derived extracellular vesicles enhance angiogenesis through miR‐126 CELL PROLIFERATION 2022
Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells CELLS 2020
Genetic lesions disrupting calreticulin 3′-untranslated region in JAK2 mutation-negative polycythemia vera AMERICAN JOURNAL OF HEMATOLOGY 2020
Ruxolitinib binding to human serum albumin. Bioinformatics, biochemical and functional characterization in JAK2V617F+ cell models SCIENTIFIC REPORTS 2019
HDAC inhibition by valproic acid decreases JAK2V617F levels in myeloproliferative neoplasms via up-regulation of miR-101, in vivo and in vitro HEMASPHERE 2018
A novel germline CALR mutation affecting an evolutionary conserved region of 3’UTR in JAK2-negative siblings with Polycythemia Vera HEMASPHERE 2018
A novel germline mutation in the 3'Untranslated region of Calreticulin gene induces JAK/STAT signaling activation and Erythrocytosis. HAEMATOLOGICA 2018
Retinoic acid receptors. From molecular mechanisms to cancer therapy MOLECULAR ASPECTS OF MEDICINE 2015
Epigenetic treatment of solid tumours. A review of clinical trials CLINICAL EPIGENETICS 2015

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma